Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1997 Dec;6(5-6):345–354. doi: 10.1080/09629359791488

Susceptibility of lung epithelium to neutrophil elastase: protection by native inhibitors

L Bingle 1, R J Richards 2, B Fox 1, L Masek 1, A Guz 1, T D Tetley 1,✉
PMCID: PMC2365876  PMID: 18472869

Abstract

The development of emphysema is thought to be due to an imbalance of proteases (especially neutrophil elastase [NE]) and antiproteases with loosening of the respiratory epithelium as an early event. We investigated the effect of NE on respiratory epithelial cell adherence in vitro , in the presence of varying concentrations and combinations of native inhibitors, α-1-proteinase inhibitor (PI) and secretory leukoprotease inhibitor (SLPI). SLPI was two to 12 times more effective than PI at preventing the effects of NE, especially when enzyme:inhibitor ratios were almost equivalent. Even when the concentration of SLPI was only 10% of the total (as in normal peripheral lung secretions), it gave greater protection than PI alone. This suggests that SLPI plays an important role in controlling neutrophil elastaseinduced inflammation and tissue damage.

Full Text

The Full Text of this article is available as a PDF (543.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amitani R., Wilson R., Rutman A., Read R., Ward C., Burnett D., Stockley R. A., Cole P. J. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol. 1991 Jan;4(1):26–32. doi: 10.1165/ajrcmb/4.1.26. [DOI] [PubMed] [Google Scholar]
  2. Auten R. L., Watkins R. H., Shapiro D. L., Horowitz S. Surfactant apoprotein A (SP-A) is synthesized in airway cells. Am J Respir Cell Mol Biol. 1990 Nov;3(5):491–496. doi: 10.1165/ajrcmb/3.5.491. [DOI] [PubMed] [Google Scholar]
  3. Beatty K., Bieth J., Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980 May 10;255(9):3931–3934. [PubMed] [Google Scholar]
  4. Bingle L., Tetley T. D. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation. Thorax. 1996 Dec;51(12):1273–1274. doi: 10.1136/thx.51.12.1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bruch M., Bieth J. G. Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor. Biochem J. 1986 Aug 15;238(1):269–273. doi: 10.1042/bj2380269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Water R., Willems L. N., Van Muijen G. N., Franken C., Fransen J. A., Dijkman J. H., Kramps J. A. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am Rev Respir Dis. 1986 May;133(5):882–890. [PubMed] [Google Scholar]
  7. Devereux T. R. Alveolar type II and Clara cells: isolation and xenobiotic metabolism. Environ Health Perspect. 1984 Jun;56:95–101. doi: 10.1289/ehp.845695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Devereux T. R., Fouts J. R. Xenobiotic metabolism by alveolar type II cells isolated from rabbit lung. Biochem Pharmacol. 1981 Jun 1;30(11):1231–1237. doi: 10.1016/0006-2952(81)90303-8. [DOI] [PubMed] [Google Scholar]
  9. Dupuit F., Jacquot J., Spilmont C., Tournier J. M., Hinnrasky J., Puchelle E. Vectorial delivery of newly-synthesized secretory proteins by human tracheal gland cells in culture. Epithelial Cell Biol. 1993 Jul;2(3):91–99. [PubMed] [Google Scholar]
  10. Evans M. J., Shami S. G., Cabral-Anderson L. J., Dekker N. P. Role of nonciliated cells in renewal of the bronchial epithelium of rats exposed to NO2. Am J Pathol. 1986 Apr;123(1):126–133. [PMC free article] [PubMed] [Google Scholar]
  11. Finlay G. A., Russell K. J., McMahon K. J., D'arcy E. M., Masterson J. B., FitzGerald M. X., O'Connor C. M. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax. 1997 Jun;52(6):502–506. doi: 10.1136/thx.52.6.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gauthier F., Fryksmark U., Ohlsson K., Bieth J. G. Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. Biochim Biophys Acta. 1982 Jan 18;700(2):178–183. doi: 10.1016/0167-4838(82)90095-4. [DOI] [PubMed] [Google Scholar]
  13. Gillissen A., Birrer P., McElvaney N. G., Buhl R., Vogelmeier C., Hoyt R. F., Jr, Hubbard R. C., Crystal R. G. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid. J Appl Physiol (1985) 1993 Aug;75(2):825–832. doi: 10.1152/jappl.1993.75.2.825. [DOI] [PubMed] [Google Scholar]
  14. Hiemstra P. S., Kramps J. A., de Vreede T. M., Breedveld F. C., Daha M. R. Inhibition of polymorphonuclear leukocyte-mediated endothelial cell detachment by antileukoprotease: a comparison with other proteinase inhibitors. Immunobiology. 1991 Mar;182(2):117–126. doi: 10.1016/S0171-2985(11)80195-6. [DOI] [PubMed] [Google Scholar]
  15. Llewellyn-Jones C. G., Lomas D. A., Stockley R. A. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. Thorax. 1994 Jun;49(6):567–572. doi: 10.1136/thx.49.6.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MACKLIN C. C. The pulmonary alveolar mucoid film and the pneumonocytes. Lancet. 1954 May 29;266(6822):1099–1104. doi: 10.1016/s0140-6736(54)92154-6. [DOI] [PubMed] [Google Scholar]
  17. Masuda K., Suga T., Takeuchi A., Kanesaki M., Imaizumi A., Suzuki Y. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva. Biochem Pharmacol. 1994 Aug 17;48(4):651–657. doi: 10.1016/0006-2952(94)90041-8. [DOI] [PubMed] [Google Scholar]
  18. McElvaney N. G., Nakamura H., Birrer P., Hébert C. A., Wong W. L., Alphonso M., Baker J. B., Catalano M. A., Crystal R. G. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest. 1992 Oct;90(4):1296–1301. doi: 10.1172/JCI115994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miller B. E., Chapin R. E., Pinkerton K. E., Gilmore L. B., Maronpot R. R., Hook G. E. Quantitation of silica-induced type II cell hyperplasia by using alkaline phosphatase histochemistry in glycol methacrylate embedded lung. Exp Lung Res. 1987;12(2):135–148. doi: 10.3109/01902148709062837. [DOI] [PubMed] [Google Scholar]
  20. Nakajima K., Powers J. C., Ashe B. M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem. 1979 May 25;254(10):4027–4032. [PubMed] [Google Scholar]
  21. Nakamura H., Yoshimura K., McElvaney N. G., Crystal R. G. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest. 1992 May;89(5):1478–1484. doi: 10.1172/JCI115738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Okada Y., Watanabe S., Nakanishi I., Kishi J., Hayakawa T., Watorek W., Travis J., Nagase H. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett. 1988 Feb 29;229(1):157–160. doi: 10.1016/0014-5793(88)80817-2. [DOI] [PubMed] [Google Scholar]
  23. Oreffo V. I., Morgan A., Richards R. J. Isolation of Clara cells from the mouse lung. Environ Health Perspect. 1990 Apr;85:51–64. doi: 10.1289/ehp.85-1568317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Palmgren M. S., deShazo R. D., Carter R. M., Zimny M. L., Shah S. V. Mechanisms of neutrophil damage to human alveolar extracellular matrix: the role of serine and metalloproteases. J Allergy Clin Immunol. 1992 Apr;89(4):905–915. doi: 10.1016/0091-6749(92)90447-a. [DOI] [PubMed] [Google Scholar]
  25. Phelps D. S., Floros J. Localization of surfactant protein synthesis in human lung by in situ hybridization. Am Rev Respir Dis. 1988 Apr;137(4):939–942. doi: 10.1164/ajrccm/137.4.939. [DOI] [PubMed] [Google Scholar]
  26. Piccioni P. D., Kramps J. A., Rudolphus A., Bulgheroni A., Luisetti M. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. Chest. 1992 Nov;102(5):1470–1476. doi: 10.1378/chest.102.5.1470. [DOI] [PubMed] [Google Scholar]
  27. Rice W. G., Weiss S. J. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science. 1990 Jul 13;249(4965):178–181. doi: 10.1126/science.2371565. [DOI] [PubMed] [Google Scholar]
  28. Richards R. J., Davies N., Atkins J., Oreffo V. I. Isolation, biochemical characterization, and culture of lung type II cells of the rat. Lung. 1987;165(3):143–158. doi: 10.1007/BF02714430. [DOI] [PubMed] [Google Scholar]
  29. Richards R. J., Oreffo V. I., Lewis R. W. Clara cell cultures from the mouse and their reaction to bronchiolar toxins. Environ Health Perspect. 1990 Apr;85:119–127. doi: 10.1289/ehp.85-1568339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rickard K. A., Taylor J., Rennard S. I. Observations of development of resistance to detachment of cultured bovine bronchial epithelial cells in response to protease treatment. Am J Respir Cell Mol Biol. 1992 Apr;6(4):414–420. doi: 10.1165/ajrcmb/6.4.414. [DOI] [PubMed] [Google Scholar]
  31. Sallenave J. M., Silva A., Marsden M. E., Ryle A. P. Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell lines. Am J Respir Cell Mol Biol. 1993 Feb;8(2):126–133. doi: 10.1165/ajrcmb/8.2.126. [DOI] [PubMed] [Google Scholar]
  32. Singh G., Singh J., Katyal S. L., Brown W. E., Kramps J. A., Paradis I. L., Dauber J. H., Macpherson T. A., Squeglia N. Identification, cellular localization, isolation, and characterization of human Clara cell-specific 10 KD protein. J Histochem Cytochem. 1988 Jan;36(1):73–80. doi: 10.1177/36.1.3275712. [DOI] [PubMed] [Google Scholar]
  33. Smith S. F., Guz A., Burton G. H., Cooke N. T., Tetley T. D. Acid-stable low molecular mass proteinase inhibitors in human lung lavage. Biol Chem Hoppe Seyler. 1986 Mar;367(3):183–189. doi: 10.1515/bchm3.1986.367.1.183. [DOI] [PubMed] [Google Scholar]
  34. Snider G. L., Lucey E. C., Stone P. J. Animal models of emphysema. Am Rev Respir Dis. 1986 Jan;133(1):149–169. doi: 10.1164/arrd.1986.133.1.149. [DOI] [PubMed] [Google Scholar]
  35. Sommerhoff C. P., Nadel J. A., Basbaum C. B., Caughey G. H. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest. 1990 Mar;85(3):682–689. doi: 10.1172/JCI114492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stolk J., Davies P., Kramps J. A., Dijkman J. H., Humes J. J., Knight W. B., Green B. G., Mumford R., Bonney R. J., Hanlon W. A. Potency of antileukoprotease and alpha 1-antitrypsin to inhibit degradation of fibrinogen by adherent polymorphonuclear leukocytes from normal subjects and patients with chronic granulomatous disease. Am J Respir Cell Mol Biol. 1992 May;6(5):521–526. doi: 10.1165/ajrcmb/6.5.521. [DOI] [PubMed] [Google Scholar]
  37. Tetley T. D., Smith S. F., Burton G. H., Winning A. J., Cooke N. T., Guz A. Effects of cigarette smoking and drugs on respiratory tract proteases and antiproteases. Eur J Respir Dis Suppl. 1987;153:93–102. [PubMed] [Google Scholar]
  38. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES